Clinical labs that have business in clinical trials involving genetic samples should note that on June 18, the Food and Drug Administration (FDA) ordered a review of new trials that send samples to “hostile countries for genetic engineering.” The FDA mentioned China specifically. The agency said it wants to stop China and other countries at […]
June 23, 2025, Intelligence: Late-Breaking Lab News
- By Scott Wallask
- > From the Volume XXXII, No. 9 - June 23, 2025 Issue
- Tags: AMP, association for molecular pathology, Beckman Coulter, China, clinical trials, FDA, Federal Register, Food and Drug Administration, genetic data, genetic engineering, genetic samples, Hologic, James Thackeray, Jim Pack, Joe Biden, laboratory-developed test, LST, Lumea, Meridian Biosciences, Ontera, Paul Marr, Thermo Fisher Scientific
